Empresa GreenLight Biosciences Holdings
Acciones
GRNA
US39536G1058
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24/07/23 |
Drew Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Amin Khan
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Nina Thayer
CMP | Compliance Officer | - | 01/03/23 |
Carole Cobb
COO | Chief Operating Officer | 66 | - |
Thomas Crampton
PRN | Corporate Officer/Principal | - | - |
Mark Singleton
PRN | Corporate Officer/Principal | 56 | - |
Charu Manocha
HRO | Human Resources Officer | 57 | 01/01/20 |
Corporate Officer/Principal | 51 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 24/07/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 151 681 314 | 119 177 217 ( 78,57 %) | 0 | 78,57 % |
Información de la empresa
GreenLight Biosciences Holdings PBC
29 Hartwell Avenue
02421, Lexington
+
http://www.greenlightbiosciences.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,51 % | 42,59 mil M | |
+8,57 % | 40,65 mil M | |
+49,22 % | 40,57 mil M | |
-12,36 % | 26,77 mil M | |
+8,92 % | 24,81 mil M | |
-25,13 % | 18,17 mil M | |
+29,17 % | 12,05 mil M | |
-3,12 % | 11,7 mil M | |
+6,35 % | 11,1 mil M |